piracetam has been researched along with Vertigo in 17 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study aimed to compare the therapeutic efficacy of dimenhydrinate and piracetam in patients with vertigo." | 9.20 | Comparison of the therapeutic efficacy of intravenous dimenhydrinate and intravenous piracetam in patients with vertigo: a randomised clinical trial. ( Avcu, N; Doğan, NÖ; Pekdemir, M; Yaka, E; Yılmaz, S, 2015) |
| "The effect of piracetam, a cyclical derivative of GABA, was compared with that of a placebo in a double-blind study of 60 patients with post-concussional syndrome of 2-12 months' duration." | 9.04 | Piracetam in the treatment of post-concussional syndrome. A double-blind study. ( Hakamies, L; Hakkarainen, H, 1978) |
| "This subanalysis compared the efficacy of betahistine plus piracetam dual therapy versus betahistine monotherapy using data from OSVaLD, a 3 month, open-label, observational study conducted in 2272 patients with peripheral vestibular vertigo." | 7.81 | Betahistine plus piracetam dual therapy versus betahistine monotherapy for peripheral vestibular vertigo: a confounder-corrected subanalysis of the OSVaLD study. ( Lilenko, SV; Melnikov, OA; Nauta, J; Ouwens, MJ, 2015) |
| "A pilot study with piracetam (Nootropil; UCB) was performed in 5 selected dizzy patients who had a diagnosis of presbyvertigo or vertebrobasilar insufficiency." | 7.67 | The use of piracetam in vertigo. ( Fernandes, CM; Samuel, J, 1985) |
| "Piracetam was found to have a significant effect on the first three." | 6.65 | The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin. ( Oosterveld, WJ, 1980) |
| "Piracetam has been shown to be effective in vertigo of both central and peripheral origin." | 6.40 | The effectiveness of piracetam in vertigo. ( Oosterveld, WJ, 1999) |
| "The present study aimed to compare the therapeutic efficacy of dimenhydrinate and piracetam in patients with vertigo." | 5.20 | Comparison of the therapeutic efficacy of intravenous dimenhydrinate and intravenous piracetam in patients with vertigo: a randomised clinical trial. ( Avcu, N; Doğan, NÖ; Pekdemir, M; Yaka, E; Yılmaz, S, 2015) |
| "The effect of piracetam, a cyclical derivative of GABA, was compared with that of a placebo in a double-blind study of 60 patients with post-concussional syndrome of 2-12 months' duration." | 5.04 | Piracetam in the treatment of post-concussional syndrome. A double-blind study. ( Hakamies, L; Hakkarainen, H, 1978) |
| "This subanalysis compared the efficacy of betahistine plus piracetam dual therapy versus betahistine monotherapy using data from OSVaLD, a 3 month, open-label, observational study conducted in 2272 patients with peripheral vestibular vertigo." | 3.81 | Betahistine plus piracetam dual therapy versus betahistine monotherapy for peripheral vestibular vertigo: a confounder-corrected subanalysis of the OSVaLD study. ( Lilenko, SV; Melnikov, OA; Nauta, J; Ouwens, MJ, 2015) |
| "A pilot study with piracetam (Nootropil; UCB) was performed in 5 selected dizzy patients who had a diagnosis of presbyvertigo or vertebrobasilar insufficiency." | 3.67 | The use of piracetam in vertigo. ( Fernandes, CM; Samuel, J, 1985) |
| "Piracetam was found to have a significant effect on the first three." | 2.65 | The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin. ( Oosterveld, WJ, 1980) |
| "Piracetam has been shown to be effective in vertigo of both central and peripheral origin." | 2.40 | The effectiveness of piracetam in vertigo. ( Oosterveld, WJ, 1999) |
| "The migraine--a benign paroxysmal vertigo of childhood complex is the most frequent etiology of pediatric dizziness, with an incidence of 34." | 1.30 | The migraine: benign paroxysmal vertigo of childhood complex. ( Arroyo, R; Calvin, FJ; de Lucas, P; Herraiz, C; Tapia, MC, 1999) |
| "Hemorheological Treatment in Vertigo." | 1.28 | [Hemorheologic therapy of asystematic vertigo]. ( Angelkort, B; Dehnert, HG; Spürk, P, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (41.18) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Molnár, A | 1 |
| Maihoub, S | 1 |
| Tamás, L | 1 |
| Szirmai, Á | 1 |
| Doğan, NÖ | 1 |
| Avcu, N | 1 |
| Yaka, E | 1 |
| Yılmaz, S | 1 |
| Pekdemir, M | 1 |
| Melnikov, OA | 1 |
| Lilenko, SV | 1 |
| Nauta, J | 1 |
| Ouwens, MJ | 1 |
| Olszewski, J | 1 |
| Repetowski, M | 1 |
| Kuśmierczyk, K | 1 |
| Mantsev, EI | 1 |
| Sigaleva, EE | 1 |
| Winblad, B | 1 |
| Oosterveld, WJ | 2 |
| Pons Rocher, F | 1 |
| Herraiz, C | 1 |
| Calvin, FJ | 1 |
| Tapia, MC | 1 |
| de Lucas, P | 1 |
| Arroyo, R | 1 |
| Wieck, HH | 1 |
| Hakkarainen, H | 1 |
| Hakamies, L | 1 |
| Spürk, P | 1 |
| Dehnert, HG | 1 |
| Angelkort, B | 1 |
| Ordosgoitia, H | 1 |
| Castro, C | 1 |
| Carbayeda, M | 1 |
| Labella, T | 1 |
| Claussen, CF | 1 |
| Schneider, D | 1 |
| Patil, NP | 1 |
| Miszke, A | 1 |
| Rapacz, K | 1 |
| Fernandes, CM | 1 |
| Samuel, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo: A Double Blind Randomized Clinical Trial[NCT01890538] | Phase 4 | 94 participants (Actual) | Interventional | 2013-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for piracetam and Vertigo
| Article | Year |
|---|---|
Piracetam: a review of pharmacological properties and clinical uses.
Topics: Anemia, Sickle Cell; Animals; Cerebrovascular Circulation; Cognition Disorders; Drug Evaluation; Dys | 2005 |
The effectiveness of piracetam in vertigo.
Topics: Controlled Clinical Trials as Topic; Humans; Neuroprotective Agents; Piracetam; Treatment Outcome; V | 1999 |
7 trials available for piracetam and Vertigo
| Article | Year |
|---|---|
Comparison of the therapeutic efficacy of intravenous dimenhydrinate and intravenous piracetam in patients with vertigo: a randomised clinical trial.
Topics: Administration, Intravenous; Adult; Aged; Antiemetics; Dimenhydrinate; Double-Blind Method; Emergenc | 2015 |
[Comparative assessment of results in cervical vertigo pharmacotherapy vs physiotherapy treatment].
Topics: Adult; Aged; Aged, 80 and over; Betahistine; Cervical Vertebrae; Female; Humans; Male; Middle Aged; | 2007 |
The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Pirac | 1980 |
[The effect of pharmacological treatment in the compensation of vertigo].
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Child; Dihydroergotoxine; Dose-Response Relat | 1999 |
Piracetam in the treatment of post-concussional syndrome. A double-blind study.
Topics: Brain Concussion; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Fatigue; Headache; | 1978 |
The treatment of minocycline-induced brainstem vertigo by the combined administration of piracetam and ergotoxin.
Topics: Adult; Brain Stem; Double-Blind Method; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Femal | 1989 |
[Treatment of vertigo syndrome with Nootropil].
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Pirac | 1988 |
8 other studies available for piracetam and Vertigo
| Article | Year |
|---|---|
Conservative Treatment Possibilities of Ménière Disease, Involving Vertigo Diaries.
Topics: Betahistine; Conservative Treatment; Drug Therapy, Combination; Female; Humans; Male; Medical Record | 2021 |
Betahistine plus piracetam dual therapy versus betahistine monotherapy for peripheral vestibular vertigo: a confounder-corrected subanalysis of the OSVaLD study.
Topics: Adult; Aged; Betahistine; Dizziness; Female; Humans; Male; Middle Aged; Odds Ratio; Piracetam; Vasod | 2015 |
[Efficacy of piracetam in vertigo].
Topics: Humans; Nootropic Agents; Piracetam; Treatment Outcome; Vertigo; Vestibule, Labyrinth | 2009 |
The migraine: benign paroxysmal vertigo of childhood complex.
Topics: Adolescent; Child; Child, Preschool; Diazepam; Dizziness; Female; Humans; Infant; Male; Migraine Dis | 1999 |
[Therapy with cerebral anti-hypoxidotics].
Topics: Humans; Hypnotics and Sedatives; Hypoxia, Brain; Meclofenoxate; Piracetam; Tranquilizing Agents; Vas | 1979 |
[Hemorheologic therapy of asystematic vertigo].
Topics: Adult; Aged; Aged, 80 and over; Carotid Stenosis; Female; Hematocrit; Hemodilution; Humans; Hydroxye | 1991 |
[Clinical trial of the use of the combination of piracetam and dihydroergocristine in vertigo from different causes].
Topics: Adult; Aged; Dihydroergotoxine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pirace | 1989 |
The use of piracetam in vertigo.
Topics: Aged; Dizziness; Electronystagmography; Female; Humans; Male; Middle Aged; Pilot Projects; Piracetam | 1985 |